1. Home
  2. ACOG vs PBHC Comparison

ACOG vs PBHC Comparison

Compare ACOG & PBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • PBHC
  • Stock Information
  • Founded
  • ACOG 2000
  • PBHC 1859
  • Country
  • ACOG Canada
  • PBHC United States
  • Employees
  • ACOG N/A
  • PBHC N/A
  • Industry
  • ACOG
  • PBHC Major Banks
  • Sector
  • ACOG
  • PBHC Finance
  • Exchange
  • ACOG Nasdaq
  • PBHC Nasdaq
  • Market Cap
  • ACOG 80.3M
  • PBHC 93.1M
  • IPO Year
  • ACOG N/A
  • PBHC N/A
  • Fundamental
  • Price
  • ACOG $8.00
  • PBHC $15.03
  • Analyst Decision
  • ACOG Strong Buy
  • PBHC
  • Analyst Count
  • ACOG 1
  • PBHC 0
  • Target Price
  • ACOG $20.00
  • PBHC N/A
  • AVG Volume (30 Days)
  • ACOG 66.4K
  • PBHC 3.0K
  • Earning Date
  • ACOG 08-14-2025
  • PBHC 07-30-2025
  • Dividend Yield
  • ACOG N/A
  • PBHC 2.66%
  • EPS Growth
  • ACOG N/A
  • PBHC N/A
  • EPS
  • ACOG N/A
  • PBHC 0.24
  • Revenue
  • ACOG $4,586,341.00
  • PBHC $39,015,000.00
  • Revenue This Year
  • ACOG N/A
  • PBHC N/A
  • Revenue Next Year
  • ACOG $149.89
  • PBHC N/A
  • P/E Ratio
  • ACOG N/A
  • PBHC $63.45
  • Revenue Growth
  • ACOG N/A
  • PBHC N/A
  • 52 Week Low
  • ACOG $3.75
  • PBHC $13.71
  • 52 Week High
  • ACOG $11.54
  • PBHC $19.86
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • PBHC 56.42
  • Support Level
  • ACOG N/A
  • PBHC $14.29
  • Resistance Level
  • ACOG N/A
  • PBHC $14.98
  • Average True Range (ATR)
  • ACOG 0.00
  • PBHC 0.25
  • MACD
  • ACOG 0.00
  • PBHC 0.03
  • Stochastic Oscillator
  • ACOG 0.00
  • PBHC 83.78

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About PBHC Pathfinder Bancorp Inc. (MD)

Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.

Share on Social Networks: